Edit |   |
---|---|
Antigenic Specificity | IL20, Human (Fletikumab biosimilar) |
Clone | Fletikumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG4 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | IF, IP, Neut, FuncS, ELISA, FCM, ICC |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human IL20 Recombinant Antibody. Fletikumab (NNC0109-0012) (INN) is a monoclonal antibody designed for the treatment of rheumatoid arthritis. This drug was being developed by Novo Nordisk A/S until Novo ceased work in inflammation. |
Immunogen | n/a |
Other Names | Anti-IL20 Recombinant Antibody, Research Grade Fletikumab, Anti-Human IL20 Recombinant Antibody, 15D2, NN-8226, NNC-0109-0012, Antibody Drug Analogues, Monoclonal Antibody, YR1322, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 1357158-22-5 |
Catalog # | YR1322 |
Price | please inquire |
Order / More Info | IL20, Human (Fletikumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |